Nasopharyngeal carcinoma epidemiology and demographics: Difference between revisions
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The [[ | The [[prevalence]] of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in US. It is one of the most common malignancies encountered in Asia, especially China. Patients of all age groups may develop nasopharyngeal carcinoma. | ||
==Epidemiology== | ==Epidemiology== |
Revision as of 15:59, 16 September 2015
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics |
FDA on Nasopharyngeal carcinoma epidemiology and demographics |
CDC on Nasopharyngeal carcinoma epidemiology and demographics |
Nasopharyngeal carcinoma epidemiology and demographics in the news |
Blogs on Nasopharyngeal carcinoma epidemiology and demographics |
Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The prevalence of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in US. It is one of the most common malignancies encountered in Asia, especially China. Patients of all age groups may develop nasopharyngeal carcinoma.
Epidemiology
Age
Patients of all age groups may develop nasopharyngeal carcinoma.
Demographics
The prevalence of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in US[1] but is extremely common in southern regions of China,[2] particularly in Guangdong, accounting for 18% of all cancers in China.[3] Nasopharyngeal carcinomas account for approximately 70% of all primary malignancies of the nasopharynx, and although it is rare in western populations, it is one of the most common malignancies encountered in Asia, especially China.[4]
References
- ↑ "Initiative for Vaccine Research (IVR): Viral cancers". World Health Organization. Retrieved 2 October 2012.
- ↑ Fang W, Li X, Jiang Q, (2008). "Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China". J Transl Med. 6: 32. doi:10.1186/1479-5876-6-32. PMC 2443113. PMID 18570662.
- ↑ Chang E T, Adami H (2006). "The Enigmatic Epidemiology of Nasopharyngeal Carcinoma". Cancer Epidemiol Biomarkers Prev. 15 (10): 1765–1777. doi:10.1158/1055-9965.EPI-06-0353. PMID 17035381.
- ↑ http://radiopaedia.org/articles/nasopharyngeal-carcinoma